Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...

Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...

After rising to prominence during the COVID-19 pandemic, South African drugmaker Aspen Pharmacare has landed in the FDA's ...

Healthcare is a defensive sector that is more resilient to economic downturns than most others. That's one of several reasons ...

OptiNose (NASDAQ:OPTN) stock surges 61% as Paratek Pharmaceuticals agrees to a $330M acquisition. Read mroe here.

BioCryst Pharmaceuticals sues Hetero with claims of Orladeyo patent infringement. Orladeyo generated $437.7 million in revenue for BioCryst last year. BioCryst seeks court order to prevent FDA ...

The tech-heavy Nasdaq Composite index is down by 8% since the beginning of the year as I write this. Whatever happens, though ...

AstraZeneca is hopping on the pickleball craze for the latest iteration of its Stepping Back Out campaign for asthma ...

Pharmaceutical stock Gilead Sciences Inc (NASDAQ:GILD) is down 2.6% at $107.34, after news that domestic HIV prevention is ...

Swiss pharmaceutical giants Roche and Novartis are revising their diversity policies in response to recent U.S. executive ...

The U.S. Health and Human Services Department is weighing plans to drastically cut federal government funding for domestic ...

Swiss drugmaker Novartis is ending its use of diverse panels for all of its hiring in the United States, the company told ...